Healthcare

Norwest Equity Partners closes GoHealth sale to Centerbridge

Norwest Equity Partners said Sept. 17 that it completed the sale of its investment in GoHealth to Centerbridge Partners. NEP is retaining a stake in GoHealth. The deal was announced in August.

PennantPark backs Pivot Health Solutions

Towson, Maryland-based Pivot Health Solutions, a provider of physical therapy, corporate wellness and occupational health services, has secured $25 million in funding. The backer was PennantPark Investment Advisers.

Mission Bay Capital raises $60 mln for third fund

Mission Bay Capital, an early-stage life science venture firm, has closed its third fund at $60 million. The fund's investors included Astellas Venture Management, Banyan Pacific Capital, Eli Lilly and Company, Mayfield, UC Investments, Wilson Sonsini Goodrich & Rosati and Zambon.

NexPhase’s Action Behavior Center returns to auction block

Firefly Health garners $10.2 mln Series A

Wellesley, Massachusetts-based Firefly Health, a technology-powered concierge medicine service for average Americans, has secured $10.2 million in Series A funding. F-Prime Capital and Oak HC/FT led the round.

PE-backed ECP completes merger with IEMS

Emergency Care Partners, which is backed by Varsity Healthcare Partners and Regal Healthcare Capital Partners, has closed its merger with Illinois Emergency Medicine Specialists, a Chicago-based provider of outsourced emergency department management services. No financial terms were disclosed. Sheppard, Mullin, Richter & Hampton LLP served as legal adviser to ECP and VHP on the deal while Nexus Health Capital and Katten Muchin Rosenman LLP acted as financial and legal advisers to IEMS.

National Partners in Healthcare invests in Arizona Heart Anesthesia

National Partners in Healthcare said Sept. 13 that it invested in Arizona Heart Anesthesia. Financial terms weren’t announced. Arizona Heart Anesthesia provides anesthesia services to hospitals and surgery centers in the greater Phoenix area.

Linden, Audax, invest in Frazier’s HOPCo in $400 mln-plus deal

SpringWorks Therapeutics debuts IPO

Stamford, Connecticut-based SpringWorks Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, has raised $162 million for its IPO after pricing its 9 million shares at $18 per share. The stock began trading September 13, 2019 on the NASDAQ under the ticker symbol "SWTX." J.P. Morgan Securities LLC, Goldman Sachs and Cowen and Company LLC are the lead underwriters. SpringWorks' pre-IPO backers include Perceptive Advisors, Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer and LifeArc.

Satsuma Pharmaceuticals goes public

Satsuma Pharmaceuticals Inc, which is focused on treating migraines, has raised $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share. The stock began trading September 13, 2019 on the NASDAQ under the ticker symbol "STSA." Credit Suisse, SVB Leerink and Evercore ISI are the lead underwriters. Satsuma's pre-IPO backers include RA Capital Management and TPG Biotech.